C.R.S. § 25-45-105: Action against health-care provider's license or medicare certification prohibited.
Where this section sits in the code
- Title 25 - PUBLIC HEALTH AND ENVIRONMENT
- Article 45 - Access to Treatments for Terminally Ill Patients
- Part 1 - INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES
Notwithstanding any other law, a licensing board may not revoke, fail to renew, suspend, or take any action against a health-care provider's license issued pursuant to title 12, C.R.S., based solely on the health-care provider's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device, as long as the recommendations are consistent with medical standards of care. Action against a health-care provider's medicare certification based solely on the health-care provider's recommendation that a patient have access to an investigational drug, biological product, or device is prohibited.
Collected 2026-09-14T18:37:45Z. Source file · JSON